{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:58:47Z","timestamp":1790819927714,"version":"4.1.0"},"reference-count":187,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.leukres.2026.108326","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:45:29Z","timestamp":1790095529000},"page":"108326","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["HTLV-1 and ATL: Decoding Molecular Pathogenesis for Next\u2010Generation Therapies"],"prefix":"10.1016","volume":"171","author":[{"given":"Mina","family":"Mohammad-rezaei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Shafaghat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5825-7122","authenticated-orcid":false,"given":"Mina","family":"Noroozbeygi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirza R.","family":"Baig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruqyia Ahmed","family":"jasim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aseel","family":"Smerat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1231-9050","authenticated-orcid":false,"given":"Faeze","family":"Fakhri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elahe","family":"Safari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Jafari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.leukres.2026.108326_bib1","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1111\/cas.13398","article-title":"Epidemiological and clinical features of adult T-cell leukemia\u2013lymphoma in Japan, 2010\u20132011: A nationwide survey","volume":"108","author":"Nosaka","year":"2017","journal-title":"Cancer Sci."},{"issue":"10","key":"10.1016\/j.leukres.2026.108326_bib2","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.1111\/cas.15097","article-title":"Epidemiology of adult T-cell leukemia-lymphoma in Japan: An updated analysis, 2012-2013","volume":"112","author":"Ito","year":"2021","journal-title":"Cancer Sci."},{"issue":"2","key":"10.1016\/j.leukres.2026.108326_bib3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s12325-018-0658-4","article-title":"A review of new findings in adult T-cell leukemia\u2013lymphoma: A focus on current and emerging treatment strategies","volume":"35","author":"Hermine","year":"2018","journal-title":"Adv. Ther."},{"key":"10.1016\/j.leukres.2026.108326_bib4","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3389\/fmicb.2012.00388","article-title":"Epidemiological aspects and world distribution of HTLV-1 infection","volume":"3","author":"Gessain","year":"2012","journal-title":"Front. Microbiol."},{"issue":"2","key":"10.1016\/j.leukres.2026.108326_bib5","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/jmv.23181","article-title":"Current prevalence of HTLV-1 in Japan as determined by screening of blood donors","volume":"84","author":"Satake","year":"2012","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.leukres.2026.108326_bib6","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3389\/fmicb.2012.00322","article-title":"Adult T-cell leukemia: a review of epidemiological evidence","volume":"3","author":"Iwanaga","year":"2012","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.leukres.2026.108326_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001160","article-title":"Adult mortality attributable to preventable risk factors for non-communicable diseases and injuries in Japan: a comparative risk assessment","volume":"9","author":"Ikeda","year":"2012","journal-title":"PLoS. Med."},{"key":"10.1016\/j.leukres.2026.108326_bib8","doi-asserted-by":"crossref","unstructured":"Osame M., Usuku K., Izumo S. HTLV-I associated myelopathy, a new clinical entity. 1986.","DOI":"10.1016\/S0140-6736(86)91298-5"},{"issue":"3","key":"10.1016\/j.leukres.2026.108326_bib9","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1349-7006.1992.tb00092.x","article-title":"HTLV-I uveitis: a distinct clinical entity caused by HTLV-I","volume":"83","author":"Mochizuki","year":"1992","journal-title":"Jpn. J. Cancer Res."},{"issue":"1","key":"10.1016\/j.leukres.2026.108326_bib10","first-page":"226","article-title":"Incidence of adult T-cell leukemia\/lymphoma among human T-lymphotropic virus type I carriers in Saga, Japan","volume":"49","author":"Tokudome","year":"1989","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.leukres.2026.108326_bib11","first-page":"1736","article-title":"How I treat adult T-cell leukemia\/lymphoma","volume":"118","author":"Bazarbachi","year":"2011","journal-title":"Blood J. Am. Soc. Hematol."},{"issue":"3","key":"10.1016\/j.leukres.2026.108326_bib12","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1200\/JCO.2008.18.2428","article-title":"Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting","volume":"27","author":"Tsukasaki","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.leukres.2026.108326_bib13","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1517\/14656566.2011.571207","article-title":"Newer developments in adult T-cell leukemia\/lymphoma therapeutics","volume":"12","author":"Dasanu","year":"2011","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.leukres.2026.108326_bib14","article-title":"Analysis of large cohort shows that Caribbean adult T cell leukemia\/lymphoma is a chemotherapy refractory disease with very poor prognosis that behaves distinctly from Japanese subtypes","author":"Zell","year":"2014","journal-title":"Am. Soc. Hematol. Wash. DC"},{"issue":"14","key":"10.1016\/j.leukres.2026.108326_bib15","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1002\/cncr.25147","article-title":"A critical analysis of prognostic factors in North American patients with human T-cell lymphotropic virus type-1-associated adult T-cell leukemia\/lymphoma: a multicenter clinicopathologic experience and new prognostic score","volume":"116","author":"Phillips","year":"2010","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.leukres.2026.108326_bib16","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/annonc\/mdn696","article-title":"The International Prognostic Index predicts outcome in aggressive adult T-cell leukemia\/lymphoma: analysis of 126 patients from the International Peripheral T-Cell Lymphoma Project","volume":"20","author":"Suzumiya","year":"2009","journal-title":"Ann. Oncol."},{"issue":"5","key":"10.1016\/j.leukres.2026.108326_bib17","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/bjh.12962","article-title":"Japan Clinical Oncology Group (JCOG) prognostic index and characterization of long-term survivors of aggressive adult T-cell leukaemia-lymphoma (JCOG0902A)","volume":"166","author":"Fukushima","year":"2014","journal-title":"Br. J. Haematol."},{"issue":"2","key":"10.1016\/j.leukres.2026.108326_bib18","doi-asserted-by":"crossref","first-page":"282","DOI":"10.5858\/arpa.2012-0379-RS","article-title":"Adult T-cell leukemia\/lymphoma","volume":"138","author":"Qayyum","year":"2014","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"5","key":"10.1016\/j.leukres.2026.108326_bib19","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s10552-019-01155-5","article-title":"Global patterns and trends in the incidence of non-Hodgkin lymphoma","volume":"30","author":"Miranda-Filho","year":"2019","journal-title":"Cancer causes & Control."},{"issue":"22","key":"10.1016\/j.leukres.2026.108326_bib20","first-page":"4337","article-title":"Long-term study of indolent adult T-cell leukemia-lymphoma","volume":"115","author":"Takasaki","year":"2010","journal-title":"Blood J. Am. Soc. Hematol."},{"issue":"8","key":"10.1016\/j.leukres.2026.108326_bib21","first-page":"1369","article-title":"Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study","volume":"116","author":"Hishizawa","year":"2010","journal-title":"Blood J. Am. Soc. Hematol."},{"issue":"8","key":"10.1016\/j.leukres.2026.108326_bib22","first-page":"1734","article-title":"Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia-lymphoma with special emphasis on preconditioning regimen: a nationwide retrospective study","volume":"120","author":"Ishida","year":"2012","journal-title":"Blood J. Am. Soc. Hematol."},{"issue":"7","key":"10.1016\/j.leukres.2026.108326_bib23","article-title":"Mechanisms of Oncogenesis by HTLV-1 Tax","volume":"9","author":"Mohanty","year":"2020","journal-title":"Pathog. [Internet]"},{"key":"10.1016\/j.leukres.2026.108326_bib24","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.3389\/fmicb.2018.01686","article-title":"HTLV-1-Mediated Epigenetic Pathway to Adult T-Cell Leukemia-Lymphoma","volume":"9","author":"Yamagishi","year":"2018","journal-title":"Front. Microbiol."},{"issue":"4","key":"10.1016\/j.leukres.2026.108326_bib25","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrc2111","article-title":"Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation","volume":"7","author":"Matsuoka","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.leukres.2026.108326_bib26","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3389\/fmicb.2012.00400","article-title":"Overview on HTLV-1 p12, p8, p30, p13: accomplices in persistent infection and viral pathogenesis","volume":"3","author":"Bai","year":"2012","journal-title":"Front. Microbiol."},{"issue":"6","key":"10.1016\/j.leukres.2026.108326_bib27","doi-asserted-by":"crossref","first-page":"861","DOI":"10.3390\/v3060861","article-title":"Orf-I and orf-II-encoded proteins in HTLV-1 infection and persistence","volume":"3","author":"Edwards","year":"2011","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.leukres.2026.108326_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010416","article-title":"NK cells and monocytes modulate primary HTLV-1 infection","volume":"18","author":"Moles","year":"2022","journal-title":"PLoS. Pathog."},{"issue":"5","key":"10.1016\/j.leukres.2026.108326_bib29","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/jnci\/93.5.367","article-title":"Somatic mutation in human T-cell leukemia virus type 1 provirus and flanking cellular sequences during clonal expansion in vivo","volume":"93","author":"Mortreux","year":"2001","journal-title":"J. Natl. Cancer Inst."},{"issue":"5","key":"10.1016\/j.leukres.2026.108326_bib30","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1128\/jvi.69.5.2863-2868.1995","article-title":"Clonal expansion of human T-cell leukemia virus type I-infected cells in asymptomatic and symptomatic carriers without malignancy","volume":"69","author":"Wattel","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.leukres.2026.108326_bib31","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3389\/fmicb.2012.00406","article-title":"HTLV tax: a fascinating multifunctional co-regulator of viral and cellular pathways","volume":"3","author":"Currer","year":"2012","journal-title":"Front. Microbiol."},{"issue":"7","key":"10.1016\/j.leukres.2026.108326_bib32","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3390\/pathogens9070543","article-title":"Mechanisms of oncogenesis by HTLV-1 Tax","volume":"9","author":"Mohanty","year":"2020","journal-title":"Pathogens"},{"key":"10.1016\/j.leukres.2026.108326_bib33","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3389\/fmicb.2013.00231","article-title":"Tax-1 and Tax-2 similarities and differences: focus on post-translational modifications and NF-\u03baB activation","volume":"4","author":"Shirinian","year":"2013","journal-title":"Front. Microbiol."},{"issue":"14","key":"10.1016\/j.leukres.2026.108326_bib34","first-page":"1790","article-title":"Polycomb-dependent epigenetic landscape in adult T-cell leukemia","volume":"127","author":"Fujikawa","year":"2016","journal-title":"Blood J. Am. Soc. Hematol."},{"issue":"1","key":"10.1016\/j.leukres.2026.108326_bib35","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2222\/jsv.62.9","article-title":"miRNA in HTLV-1 related disease","volume":"62","author":"Yamagishi","year":"2012","journal-title":"Uirusu"},{"issue":"4","key":"10.1016\/j.leukres.2026.108326_bib36","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3390\/pathogens8040290","article-title":"NF-\u03baB and MicroRNA deregulation mediated by HTLV-1 tax and HBZ","volume":"8","author":"Fochi","year":"2019","journal-title":"Pathogens"},{"issue":"6","key":"10.1016\/j.leukres.2026.108326_bib37","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1158\/0008-5472.CAN-03-2390","article-title":"Human T-cell lymphotropic virus type I-infected cells extravasate through the endothelial barrier by a local angiogenesis-like mechanism","volume":"64","author":"Bazarbachi","year":"2004","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.leukres.2026.108326_bib38","first-page":"3383","article-title":"Human T-cell lymphotropic virus type 1\u2013transformed cells induce angiogenesis and establish functional gap junctions with endothelial cells","volume":"99","author":"El-Sabban","year":"2002","journal-title":"Blood J. Am. Soc. Hematol."},{"issue":"1","key":"10.1016\/j.leukres.2026.108326_bib39","first-page":"190","article-title":"Tax ubiquitylation and SUMOylation control the dynamic shuttling of Tax and NEMO between Ubc9 nuclear bodies and the centrosome","volume":"117","author":"Kfoury","year":"2011","journal-title":"Blood J. Am. Soc. Hematol."},{"issue":"23","key":"10.1016\/j.leukres.2026.108326_bib40","doi-asserted-by":"crossref","first-page":"10391","DOI":"10.1128\/MCB.25.23.10391-10406.2005","article-title":"Exclusive ubiquitination and sumoylation on overlapping lysine residues mediate NF-\u03baB activation by the human T-cell leukemia VirusTax oncoprotein","volume":"25","author":"Lamsoul","year":"2005","journal-title":"Mol. Cell. Biol."},{"issue":"6","key":"10.1016\/j.leukres.2026.108326_bib41","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3390\/v8060161","article-title":"HTLV-1 infection and adult T-cell leukemia\/lymphoma\u2014a tale of two proteins: tax and HBZ","volume":"8","author":"Giam","year":"2016","journal-title":"Viruses"},{"issue":"24","key":"10.1016\/j.leukres.2026.108326_bib42","doi-asserted-by":"crossref","first-page":"12813","DOI":"10.1128\/JVI.76.24.12813-12822.2002","article-title":"The complementary strand of the human T-cell leukemia virus type 1 RNA genome encodes a bZIP transcription factor that down-regulates viral transcription","volume":"76","author":"Gaudray","year":"2002","journal-title":"J. Virol."},{"issue":"44","key":"10.1016\/j.leukres.2026.108326_bib43","doi-asserted-by":"crossref","first-page":"43620","DOI":"10.1074\/jbc.M307275200","article-title":"The HBZ factor of human T-cell leukemia virus type I dimerizes with transcription factors JunB and c-Jun and modulates their transcriptional activity","volume":"278","author":"Basbous","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.leukres.2026.108326_bib44","doi-asserted-by":"crossref","unstructured":"Thebault S., Lemasson I., Mesnard J.-M., Barbeau B., Nyborg J.K., Lewis M.R., et al. Human T-Cell Leukemia Virus Type 1 (HTLV-1) bZIP Protein Interacts with the Cellular Transcription Factor CREB To Inhibit HTLV-1 Transcription. 2007.","DOI":"10.1128\/JVI.00480-06"},{"issue":"1","key":"10.1016\/j.leukres.2026.108326_bib45","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1146\/annurev.immunol.19.1.475","article-title":"Multiple viral strategies of HTLV-1 for dysregulation of cell growth control","volume":"19","author":"Yoshida","year":"2001","journal-title":"Annu. Rev. Immunol."},{"issue":"1-3","key":"10.1016\/j.leukres.2026.108326_bib46","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0014-5793(04)00225-X","article-title":"HBZ interacts with JunD and stimulates its transcriptional activity","volume":"562","author":"Th\u00e9bault","year":"2004","journal-title":"FEBS Lett."},{"issue":"36","key":"10.1016\/j.leukres.2026.108326_bib47","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1038\/onc.2012.450","article-title":"HTLV-1 bZIP factor dysregulates the Wnt pathways to support proliferation and migration of adult T-cell leukemia cells","volume":"32","author":"Ma","year":"2013","journal-title":"Oncogene"},{"issue":"17","key":"10.1016\/j.leukres.2026.108326_bib48","doi-asserted-by":"crossref","first-page":"5068","DOI":"10.1158\/0008-5472.CAN-16-0361","article-title":"HTLV-1 viral factor HBZ induces CCR4 to promote T-cell migration and proliferation","volume":"76","author":"Sugata","year":"2016","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.leukres.2026.108326_bib49","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12977-016-0249-x","article-title":"Multifaceted functions and roles of HBZ in HTLV-1 pathogenesis","volume":"13","author":"Ma","year":"2016","journal-title":"Retrovirology"},{"issue":"12","key":"10.1016\/j.leukres.2026.108326_bib50","first-page":"2755","article-title":"Human T-cell leukemia virus type 1 bZIP factor selectively suppresses the classical pathway of NF-\u03baB","volume":"113","author":"Zhao","year":"2009","journal-title":"Blood J. Am. Soc. Hematol."},{"issue":"1","key":"10.1016\/j.leukres.2026.108326_bib51","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1146\/annurev-immunol-042617-053222","article-title":"Human T cell leukemia virus type 1: persistence and pathogenesis","volume":"36","author":"Bangham","year":"2018","journal-title":"Annu. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.leukres.2026.108326_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002025","article-title":"NF-\u03baB hyper-activation by HTLV-1 tax induces cellular senescence, but can be alleviated by the viral anti-sense protein HBZ","volume":"7","author":"Zhi","year":"2011","journal-title":"PLoS. Pathog."},{"issue":"1","key":"10.1016\/j.leukres.2026.108326_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009219","article-title":"vivo antagonistic role of the Human T-Cell Leukemia Virus Type 1 regulatory proteins Tax and HBZ","volume":"17","author":"Akkouche","year":"2021","journal-title":"PLoS. Pathog."},{"issue":"48","key":"10.1016\/j.leukres.2026.108326_bib54","doi-asserted-by":"crossref","first-page":"20738","DOI":"10.1073\/pnas.1009635107","article-title":"Human T-cell leukemia virus type 1 p8 protein increases cellular conduits and virus transmission","volume":"107","author":"Van Prooyen","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"5","key":"10.1016\/j.leukres.2026.108326_bib55","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.mam.2010.03.001","article-title":"HTLV-1 p13, a small protein with a busy agenda","volume":"31","author":"Silic-Benussi","year":"2010","journal-title":"Mol. Asp. Med."},{"issue":"39","key":"10.1016\/j.leukres.2026.108326_bib56","doi-asserted-by":"crossref","first-page":"5938","DOI":"10.1038\/sj.onc.1208973","article-title":"Transcriptional and post-transcriptional gene regulation of HTLV-1","volume":"24","author":"Kashanchi","year":"2005","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.leukres.2026.108326_bib57","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1128\/JVI.80.5.2495-2505.2006","article-title":"A novel alternative splicing isoform of human T-cell leukemia virus type 1 bZIP factor (HBZ-SI) targets distinct subnuclear localization","volume":"80","author":"Murata","year":"2006","journal-title":"J. Virol."},{"issue":"12","key":"10.1016\/j.leukres.2026.108326_bib58","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s13238-021-00846-7","article-title":"Metabolic reprogramming and epigenetic modifications on the path to cancer","volume":"13","author":"Sun","year":"2022","journal-title":"Protein & Cell."},{"issue":"1","key":"10.1016\/j.leukres.2026.108326_bib59","article-title":"Epigenetic Regulation of Human T-Cell Leukemia Virus Gene Expression","volume":"10","author":"Ratner","year":"2022","journal-title":"Microorg. [Internet]"},{"key":"10.1016\/j.leukres.2026.108326_bib60","article-title":"Advances in epigenetic treatment of adult T-cell leukemia\/lymphoma","author":"Letafati","year":"2025","journal-title":"a Compr."},{"issue":"12","key":"10.1016\/j.leukres.2026.108326_bib61","doi-asserted-by":"crossref","first-page":"326","DOI":"10.31083\/j.fbl2712326","article-title":"DNA methylation: from cancer biology to clinical perspectives","volume":"27","author":"Chen","year":"2022","journal-title":"Front. Biosci. -Landmark"},{"issue":"4","key":"10.1016\/j.leukres.2026.108326_bib62","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/s12185-023-03547-5","article-title":"Viral, genetic, and immune factors in the oncogenesis of adult T-cell leukemia\/lymphoma","volume":"117","author":"Yasunaga","year":"2023","journal-title":"Int. J. Hematol."},{"issue":"10","key":"10.1016\/j.leukres.2026.108326_bib63","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.3390\/biom13101543","article-title":"Understanding the immunopathology of HTLV-1-associated adult T-cell leukemia\/lymphoma: a comprehensive review","volume":"13","author":"Nakahata","year":"2023","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.leukres.2026.108326_bib64","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12977-020-0511-0","article-title":"HTLV-1 bZIP factor: the key viral gene for pathogenesis","volume":"17","author":"Matsuoka","year":"2020","journal-title":"Retrovirology"},{"issue":"10","key":"10.1016\/j.leukres.2026.108326_bib65","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.3390\/cancers14102394","article-title":"Genetic alterations in adult T-cell leukemia\/lymphoma: novel discoveries with clinical and biological significance","volume":"14","author":"Sakihama","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.leukres.2026.108326_bib66","doi-asserted-by":"crossref","DOI":"10.18502\/ijml.v6i3.1396","article-title":"DNA Methylation and Its Role in the Development of Leukemia","author":"Bagheri","year":"2019","journal-title":"Int. J. Med. Lab."},{"key":"10.1016\/j.leukres.2026.108326_bib67","article-title":"Therapeutic Implication of SOCS1 Modulation in the Treatment of Autoimmunity and Cancer","volume":"10 - 2019","author":"Sharma","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"7","key":"10.1016\/j.leukres.2026.108326_bib68","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1182\/blood.2019003084","article-title":"Targeting aberrant DNA hypermethylation as a driver of ATL leukemogenesis by using the new oral demethylating agent OR-2100","volume":"136","author":"Watanabe","year":"2020","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.leukres.2026.108326_bib69","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1182\/blood-2016-09-692574","article-title":"Adult T-cell leukemia: molecular basis for clonal expansion and transformation of HTLV-1\u2013infected T cells","volume":"129","author":"Watanabe","year":"2017","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.leukres.2026.108326_bib70","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s10238-025-01783-z","article-title":"The epigenetic revolution in hematology: from benchside breakthroughs to clinical transformations","volume":"25","author":"Abdar Esfahani","year":"2025","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.leukres.2026.108326_bib71","article-title":"Recent progress in DNA methyltransferase inhibitors as anticancer agents","volume":"13 - 2022","author":"Zhang","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.leukres.2026.108326_bib72","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/s41392-024-02039-0","article-title":"Epigenetics-targeted drugs: current paradigms and future challenges","volume":"9","author":"Dai","year":"2024","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"6","key":"10.1016\/j.leukres.2026.108326_bib73","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.molonc.2012.09.005","article-title":"Chromatin remodeling in cancer: a gateway to regulate gene transcription","volume":"6","author":"Nair","year":"2012","journal-title":"Mol. Oncol."},{"issue":"2","key":"10.1016\/j.leukres.2026.108326_bib74","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/cas.16388","article-title":"Rewired chromatin structure and epigenetic gene dysregulation during HTLV-1 infection to leukemogenesis","volume":"116","author":"Mizuike","year":"2025","journal-title":"Cancer Sci."},{"issue":"2","key":"10.1016\/j.leukres.2026.108326_bib75","first-page":"175","article-title":"Diverse involvement of EZH2 in cancer epigenetics","volume":"7","author":"V\u00f6lkel","year":"2015","journal-title":"Am. J. Transl. Res."},{"issue":"1","key":"10.1016\/j.leukres.2026.108326_bib76","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ccr.2011.12.015","article-title":"Polycomb-Mediated Loss of miR-31 Activates NIK-Dependent NF-\u03baB Pathway in Adult T Cell Leukemia and Other Cancers","volume":"21","author":"Yamagishi","year":"2012","journal-title":"Cancer Cell."},{"key":"10.1016\/j.leukres.2026.108326_bib77","doi-asserted-by":"crossref","DOI":"10.1177\/17588359241306026","article-title":"Exploring oncogenic roles and clinical significance of EZH2: focus on non-canonical activities","volume":"17","author":"Wozniak","year":"2025","journal-title":"Ther. Adv. Med. Oncol."},{"issue":"5","key":"10.1016\/j.leukres.2026.108326_bib78","doi-asserted-by":"crossref","DOI":"10.1172\/JCI152394","article-title":"EZH2-triggered methylation of SMAD3 promotes its activation and tumor metastasis","volume":"132","author":"Huang","year":"2022","journal-title":"J. Clin. Investig."},{"issue":"11","key":"10.1016\/j.leukres.2026.108326_bib79","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.70025","article-title":"EZH2 Activates HTLV-1 bZIP Factor-Mediated TGF-\u03b2 Signaling in Adult T-Cell Leukemia","volume":"96","author":"Zhang","year":"2024","journal-title":"J. Med. Virol."},{"issue":"5","key":"10.1016\/j.leukres.2026.108326_bib80","doi-asserted-by":"crossref","DOI":"10.3390\/genes11050556","article-title":"Histone Deacetylases (HDACs): Evolution, Specificity, Role in Transcriptional Complexes, and Pharmacological Actionability","volume":"11","author":"Milazzo","year":"2020","journal-title":"Genes"},{"key":"10.1016\/j.leukres.2026.108326_bib81","first-page":"2025","article-title":"Mechanisms of HDACs in cancer development","volume":"16","author":"Zhang","year":"2025","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.leukres.2026.108326_bib82","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.18632\/oncotarget.6424","article-title":"Human T-cell leukemia virus type-1-encoded protein HBZ represses p53 function by inhibiting the acetyltransferase activity of p300\/CBP and HBO1","volume":"7","author":"Wright","year":"2016","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.leukres.2026.108326_bib83","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.3390\/molecules20033898","article-title":"Histone Deacetylase Inhibitors in Clinical Studies as Templates for New Anticancer Agents","volume":"20","author":"Mottamal","year":"2015","journal-title":"Mol. [Internet]"},{"key":"10.1016\/j.leukres.2026.108326_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2025.107057","article-title":"Clinical efficacy and mechanistic insights of FDA-approved HDAC inhibitors in the treatment of lymphoma","volume":"208","author":"El Omari","year":"2025","journal-title":"Eur. J. Pharm. Sci."},{"issue":"17","key":"10.1016\/j.leukres.2026.108326_bib85","doi-asserted-by":"crossref","first-page":"5271","DOI":"10.1158\/1078-0432.CCR-18-3989","article-title":"Precision Targeting with EZH2 and HDAC Inhibitors in Epigenetically Dysregulated Lymphomas","volume":"25","author":"Lue","year":"2019","journal-title":"Clinical cancer research official journal American Association Cancer Research"},{"issue":"19","key":"10.1016\/j.leukres.2026.108326_bib86","doi-asserted-by":"crossref","first-page":"12838","DOI":"10.1021\/acs.jmedchem.2c00673","article-title":"Histone Deacetylase and Enhancer of Zeste Homologue 2 Dual Inhibitors Presenting a Synergistic Effect for the Treatment of Hematological Malignancies","volume":"65","author":"Lu","year":"2022","journal-title":"J. Med. Chem."},{"issue":"10","key":"10.1016\/j.leukres.2026.108326_bib87","article-title":"Role of miRNAs in Human T Cell Leukemia Virus Type 1 Induced T Cell Leukemia: A Literature Review and Bioinformatics Approach","volume":"23","author":"Machado","year":"2022","journal-title":"Int. J. Mol. Sci. [Internet]"},{"issue":"1","key":"10.1016\/j.leukres.2026.108326_bib88","article-title":"Important Roles of Cellular MicroRNA miR-155 in Leukemogenesis by Human T-Cell Leukemia Virus Type 1 Infection","volume":"2012","author":"Tomita","year":"2012","journal-title":"Int. Sch. Res. Not."},{"issue":"6","key":"10.1016\/j.leukres.2026.108326_bib89","doi-asserted-by":"crossref","first-page":"8465","DOI":"10.1002\/jcp.27776","article-title":"MicroRNA in leukemia: Tumor suppressors and oncogenes with prognostic potential","volume":"234","author":"Mardani","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.leukres.2026.108326_bib90","article-title":"Dynamic Roles of RNA and RNA Epigenetics in HTLV-1 Biology","volume":"17","author":"King","year":"2025","journal-title":"Virus [Internet]"},{"key":"10.1016\/j.leukres.2026.108326_bib91","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3389\/fmicb.2018.00285","article-title":"HTLV deregulation of the NF-\u03baB pathway: An update on tax and antisense proteins role","volume":"9","author":"Fochi","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.leukres.2026.108326_bib92","article-title":"Expression of miR-34a in T-Cells Infected by Human T-Lymphotropic Virus 1","volume":"9 - 2018","author":"Sharma","year":"2018","journal-title":"Front. Microbiol."},{"issue":"24","key":"10.1016\/j.leukres.2026.108326_bib93","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00909-18","article-title":"Long Noncoding RNA ANRIL Supports Proliferation of Adult T-Cell Leukemia Cells through Cooperation with EZH2","volume":"92","author":"Song","year":"2018","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.leukres.2026.108326_bib94","article-title":"New Insights into Long Non-Coding RNA MALAT1 in Cancer and Metastasis","volume":"11","author":"Sun","year":"2019","journal-title":"Cancers [Internet]"},{"issue":"1","key":"10.1016\/j.leukres.2026.108326_bib95","first-page":"19","article-title":"MALAT1: A long non\u2011coding RNA highly associated with human cancers (Review)","volume":"16","author":"Zhao","year":"2018","journal-title":"Oncol. Lett."},{"issue":"2","key":"10.1016\/j.leukres.2026.108326_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2021.188502","article-title":"Diagnostic, prognostic, and therapeutic significance of long non-coding RNA MALAT1 in cancer","volume":"1875","author":"Goyal","year":"2021","journal-title":"Biochimica et Biophysica Acta (BBA) - Reviews Cancer"},{"key":"10.1016\/j.leukres.2026.108326_bib97","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.canlet.2021.02.004","article-title":"CircRNA in cancer: Fundamental mechanism and clinical potential","volume":"505","author":"Chen","year":"2021","journal-title":"Cancer Lett."},{"issue":"6","key":"10.1016\/j.leukres.2026.108326_bib98","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1111\/jcmm.16102","article-title":"Circular RNA in cancer development and immune regulation","volume":"26","author":"Li","year":"2022","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.leukres.2026.108326_bib99","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.875211","article-title":"Functional and Pathogenic Roles of Retroviral Antisense Transcripts","volume":"13","author":"Toyoda","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.leukres.2026.108326_bib100","article-title":"HTLV-1's Foxy Strategy for Survival and Transmission","volume":"1 - 2021","author":"Higuchi","year":"2022","journal-title":"Front. Virol."},{"key":"10.1016\/j.leukres.2026.108326_bib101","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.991928","article-title":"HTLV-1 persistence and leukemogenesis: A game of hide-and-seek with the host immune system","volume":"13","author":"Tan","year":"2022","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.leukres.2026.108326_bib102","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/s41379-020-00654-0","article-title":"Human T-cell lymphotropic virus <em>HBZ<\/em> and <em>tax<\/em> mRNA expression are associated with specific clinicopathological features in adult T-cell leukemia\/lymphoma","volume":"34","author":"Yamada","year":"2021","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.leukres.2026.108326_bib103","article-title":"HTLV-1 Alters T Cells for Viral Persistence and Transmission","volume":"9 - 2018","author":"Tanaka","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.leukres.2026.108326_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2024.107635","article-title":"Immunological aspects of HTLV-1 persistence; for the prevention and treatment of Adult T-cell leukaemia-lymphoma (ATL)","volume":"148","author":"Weterings","year":"2025","journal-title":"Leuk. Res."},{"issue":"Pt 3","key":"10.1016\/j.leukres.2026.108326_bib105","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.semcancer.2022.03.014","article-title":"Immune checkpoint proteins: Signaling mechanisms and molecular interactions in cancer immunotherapy","volume":"86","author":"Gaikwad","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"2","key":"10.1016\/j.leukres.2026.108326_bib106","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00277-017-3146-z","article-title":"Expression of PD-1 and PD-L1 on cytotoxic T lymphocytes and immune deficiency in a patient with adult T cell leukemia\/lymphoma","volume":"97","author":"Yanagihara","year":"2018","journal-title":"Ann. Hematol."},{"issue":"7","key":"10.1016\/j.leukres.2026.108326_bib107","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.pathol.2024.06.003","article-title":"TIGIT expression on neoplastic cells is a poor prognostic factor for adult T-cell leukaemia\/lymphoma","volume":"56","author":"Yamada","year":"2024","journal-title":"Pathology"},{"issue":"5","key":"10.1016\/j.leukres.2026.108326_bib108","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens12050735","article-title":"Mechanisms of Innate Immune Sensing of HTLV-1 and Viral Immune Evasion","volume":"12","author":"Mohanty","year":"2023","journal-title":"Pathogens"},{"issue":"8","key":"10.1016\/j.leukres.2026.108326_bib109","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1111\/cas.13654","article-title":"Human T-cell lymphotropic\/leukemia virus type 1 (HTLV-1) Tax-specific T-cell exhaustion in HTLV-1-infected individuals","volume":"109","author":"Masaki","year":"2018","journal-title":"Cancer Sci."},{"issue":"2","key":"10.1016\/j.leukres.2026.108326_bib110","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1182\/blood-2011-05-357459","article-title":"HTLV-1 bZIP factor impairs cell-mediated immunity by suppressing production of Th1 cytokines","volume":"119","author":"Sugata","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2026.108326_bib111","article-title":"Therapeutic approaches to enhance natural killer cell cytotoxicity","volume":"15 - 2024","author":"Stenger","year":"2024","journal-title":"Front. Immunol."},{"issue":"18","key":"10.1016\/j.leukres.2026.108326_bib112","doi-asserted-by":"crossref","first-page":"9707","DOI":"10.1128\/JVI.00887-07","volume":"81","author":"Banerjee","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.leukres.2026.108326_bib113","series-title":"Antigen Processing: Methods and Protocols","first-page":"187","article-title":"A Flow Cytometry-Based Approach to Unravel Viral Interference with the MHC Class I Antigen Processing and Presentation Pathway","author":"Praest","year":"2019"},{"issue":"12","key":"10.1016\/j.leukres.2026.108326_bib114","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1038\/s41591-019-0675-0","article-title":"Chronic inflammation in the etiology of disease across the life span","volume":"25","author":"Furman","year":"2019","journal-title":"Nat. Med."},{"issue":"18","key":"10.1016\/j.leukres.2026.108326_bib115","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1111\/febs.14492","article-title":"NF-\u03baB signaling mechanisms in HTLV-1-induced adult T-cell leukemia\/lymphoma","volume":"285","author":"Harhaj","year":"2018","journal-title":"FEBS J."},{"issue":"5","key":"10.1016\/j.leukres.2026.108326_bib116","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1111\/cas.14869","article-title":"Adult T-cell leukemia-lymphoma as a viral disease: Subtypes based on viral aspects","volume":"112","author":"Nosaka","year":"2021","journal-title":"Cancer Sci."},{"issue":"12","key":"10.1016\/j.leukres.2026.108326_bib117","article-title":"Cytokine Networks Dysregulation during HTLV-1 Infection and Associated Diseases","volume":"10","author":"Futsch","year":"2018","journal-title":"Virus [Internet]"},{"key":"10.1016\/j.leukres.2026.108326_bib118","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.3389\/fmicb.2020.00421","article-title":"The Role of Chemokines in the Pathogenesis of HTLV-1","volume":"11","author":"Zargari","year":"2020","journal-title":"Front. Microbiol."},{"issue":"5","key":"10.1016\/j.leukres.2026.108326_bib119","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1182\/blood.V99.5.1505","article-title":"Frequent expression of CCR4 in adult T-cell leukemia and human T-cell leukemia virus type 1\u2013transformed T cells","volume":"99","author":"Yoshie","year":"2002","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.leukres.2026.108326_bib120","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1038\/s12276-024-01335-7","article-title":"Cells and signals of the leukemic microenvironment that support progression of T-cell acute lymphoblastic leukemia (T-ALL)","volume":"56","author":"Lyu","year":"2024","journal-title":"Exp. & Mol. Med."},{"issue":"1","key":"10.1016\/j.leukres.2026.108326_bib121","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/MOH.0000000000000621","article-title":"Structural organization of the bone marrow and its role in hematopoiesis","volume":"28","author":"Lucas","year":"2021","journal-title":"Curr. Opin. Hematol."},{"issue":"8","key":"10.1016\/j.leukres.2026.108326_bib122","doi-asserted-by":"crossref","first-page":"476","DOI":"10.4252\/wjsc.v11.i8.476","article-title":"Bone marrow microenvironment: The guardian of leukemia stem cells","volume":"11","author":"Houshmand","year":"2019","journal-title":"World J. stem Cells"},{"issue":"5","key":"10.1016\/j.leukres.2026.108326_bib123","doi-asserted-by":"crossref","first-page":"749","DOI":"10.2217\/fon.13.193","article-title":"CXCL12\u2013CXCR4 Contributes to the Implication of Bone Marrow in Cancer Metastasis","volume":"10","author":"Shi","year":"2014","journal-title":"Future Oncol."},{"key":"10.1016\/j.leukres.2026.108326_bib124","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.574667","article-title":"The Role of the CXCL12\/CXCR4\/CXCR7 Chemokine Axis in Cancer","volume":"11","author":"Shi","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.leukres.2026.108326_bib125","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.3389\/fimmu.2022.884024","article-title":"Bone Marrow Niches and Tumour Cells: Lights and Shadows of a Mutual Relationship","volume":"13","author":"Granata","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.leukres.2026.108326_bib126","article-title":"FAd. Emerging Role of Mesenchymal Stromal Cell-Derived Extracellular Vesicles in Pathogenesis of Haematological Malignancies","volume":"2019","author":"Cominal","year":"2019","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.leukres.2026.108326_bib127","article-title":"Insights Into Bone Marrow Niche Stability: An Adhesion and Metabolism Route","volume":"9","author":"Ashok","year":"2021","journal-title":"Front. Cell. Dev. Biol."},{"key":"10.1016\/j.leukres.2026.108326_bib128","article-title":"CAM-DR: Mechanisms, Roles and Clinical Application in Tumors","volume":"9 - 2021","author":"Huang","year":"2021","journal-title":"Front. Cell. Dev. Biol."},{"issue":"1","key":"10.1016\/j.leukres.2026.108326_bib129","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12929-024-01055-0","article-title":"Exosomes: A review of biologic function, diagnostic and targeted therapy applications, and clinical trials","volume":"31","author":"Chen","year":"2024","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.leukres.2026.108326_bib130","author":"Joseph","year":"2024","journal-title":"Regul. Immun. via Exosomes Retroviral bZip Protein HBZ HTLV-1-Induc. Neuroinflamm."},{"issue":"12","key":"10.1016\/j.leukres.2026.108326_bib131","article-title":"Extracellular Vesicles in HTLV-1 Communication: The Story of an Invisible Messenger","volume":"12","author":"Al Sharif","year":"2020","journal-title":"Virus [Internet]"},{"issue":"1","key":"10.1016\/j.leukres.2026.108326_bib132","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13027-025-00658-y","article-title":"HTLV-1 infection and microRNAs: unraveling the complex crosstalk","volume":"20","author":"Edalat","year":"2025","journal-title":"Infect. Agents Cancer"},{"issue":"1","key":"10.1016\/j.leukres.2026.108326_bib133","article-title":"Circulating exosomes as an enriched source for adult T-cell leukemia biomarkers","volume":"12","author":"Dutta","year":"2015","journal-title":"Retrovirology"},{"issue":"10","key":"10.1016\/j.leukres.2026.108326_bib134","doi-asserted-by":"crossref","first-page":"16307","DOI":"10.1002\/jcb.29018","article-title":"Leukemia-derived exosomes: Bringing oncogenic signals to blood cells","volume":"120","author":"Sharifi","year":"2019","journal-title":"J. Cell. Biochem."},{"issue":"26","key":"10.1016\/j.leukres.2026.108326_bib135","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1056\/NEJM199506293322603","article-title":"Treatment of adult T-cell leukemia\u2013lymphoma with a combination of interferon alfa and zidovudine","volume":"332","author":"Gill","year":"1995","journal-title":"New. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.leukres.2026.108326_bib136","first-page":"1017","article-title":"Single platelets seal neutrophil-induced vascular breaches via GPVI during immune-complex\u2013mediated inflammation in mice","volume":"126","author":"Gros","year":"2015","journal-title":"Blood J. Am. Soc. Hematol."},{"issue":"11","key":"10.1016\/j.leukres.2026.108326_bib137","doi-asserted-by":"crossref","first-page":"e517","DOI":"10.1016\/S1470-2045(14)70202-5","article-title":"Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma","volume":"15","author":"Ishitsuka","year":"2014","journal-title":"Lancet Oncol."},{"issue":"7607","key":"10.1016\/j.leukres.2026.108326_bib138","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nature18294","article-title":"Aberrant PD-L1 expression through 3\u2032-UTR disruption in multiple cancers","volume":"534","author":"Kataoka","year":"2016","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.leukres.2026.108326_bib139","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/s41419-020-03144-y","article-title":"Targeting BCL-2 in B-cell malignancies and overcoming therapeutic resistance","volume":"11","author":"Kapoor","year":"2020","journal-title":"Cell. death & Dis."},{"issue":"1","key":"10.1016\/j.leukres.2026.108326_bib140","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s13045-020-01006-w","article-title":"Novel targeted therapies of T cell lymphomas","volume":"13","author":"I\u017cykowska","year":"2020","journal-title":"J. Hematol. & Oncol."},{"issue":"14","key":"10.1016\/j.leukres.2026.108326_bib141","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1182\/bloodadvances.2022008327","article-title":"Identifying highly active anti-CCR4 CAR T cells for the treatment of T-cell lymphoma","volume":"7","author":"Watanabe","year":"2023","journal-title":"Blood Adv."},{"issue":"1","key":"10.1016\/j.leukres.2026.108326_bib142","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ccr.2011.12.015","article-title":"Polycomb-mediated loss of miR-31 activates NIK-dependent NF-\u03baB pathway in adult T cell leukemia and other cancers","volume":"21","author":"Yamagishi","year":"2012","journal-title":"Cancer Cell."},{"issue":"11","key":"10.1016\/j.leukres.2026.108326_bib143","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/ng.3415","article-title":"Integrated molecular analysis of adult T cell leukemia\/lymphoma","volume":"47","author":"Kataoka","year":"2015","journal-title":"Nat. Genet."},{"issue":"8","key":"10.1016\/j.leukres.2026.108326_bib144","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1200\/JCO.18.00501","article-title":"Revised adult T-cell leukemia-lymphoma international consensus meeting report","volume":"37","author":"Cook","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.leukres.2026.108326_bib145","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nm.3048","article-title":"ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets","volume":"19","author":"Souers","year":"2013","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.leukres.2026.108326_bib146","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3390\/v10020083","article-title":"Impact of mutations in the hemagglutinin of H10N7 viruses isolated from seals on virus replication in avian and human cells","volume":"10","author":"Dittrich","year":"2018","journal-title":"Viruses"},{"issue":"9","key":"10.1016\/j.leukres.2026.108326_bib147","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1038\/leu.2013.163","article-title":"Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study","volume":"27","author":"Tefferi","year":"2013","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.leukres.2026.108326_bib148","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1513257","article-title":"Targeting BCL2 with venetoclax in relapsed chronic lymphocytic leukemia","volume":"374","author":"Roberts","year":"2016","journal-title":"New. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.leukres.2026.108326_bib149","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1200\/JCO.2011.37.3472","article-title":"Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study","volume":"30","author":"Ishida","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.leukres.2026.108326_bib150","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1080\/14712598.2017.1347634","article-title":"Mogamulizumab for the treatment of T-cell lymphoma","volume":"17","author":"Makita","year":"2017","journal-title":"Expert. Opin. Biol. Ther."},{"issue":"1_ement","key":"10.1016\/j.leukres.2026.108326_bib151","article-title":"Anti-CCR4 antibody enhances anti-tumor immunity by modulating tumor-infiltrating Tregs in an ovarian cancer xenograft animal model (VAC12P. 1121)","volume":"194","author":"Chang","year":"2015","journal-title":"J. Immunol."},{"issue":"44","key":"10.1016\/j.leukres.2026.108326_bib152","doi-asserted-by":"crossref","first-page":"17945","DOI":"10.1073\/pnas.1316796110","article-title":"Anti-CCR4 mAb selectively depletes effector-type FoxP3+ CD4+ regulatory T cells, evoking antitumor immune responses in humans","volume":"110","author":"Sugiyama","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"9","key":"10.1016\/j.leukres.2026.108326_bib153","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/S1470-2045(18)30379-6","article-title":"Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial","volume":"19","author":"Kim","year":"2018","journal-title":"Lancet Oncol."},{"issue":"9","key":"10.1016\/j.leukres.2026.108326_bib154","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/ajh.24794","article-title":"Chimeric antigen receptor modified T cells that target chemokine receptor CCR4 as a therapeutic modality for T-cell malignancies","volume":"92","author":"Perera","year":"2017","journal-title":"Am. J. Hematol."},{"issue":"4","key":"10.1016\/j.leukres.2026.108326_bib155","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.bbmt.2011.11.016","article-title":"IL-2\u2013Targeted Therapy Ameliorates the Severity of Graft-versus-Host Disease: Ex Vivo Selective Depletion of Host-Reactive T Cells and In Vivo Therapy","volume":"18","author":"Yarkoni","year":"2012","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"9","key":"10.1016\/j.leukres.2026.108326_bib156","first-page":"3281","article-title":"Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitin-proteasome pathway, against preclinical models of multiple myeloma","volume":"110","author":"Kuhn","year":"2007","journal-title":"Blood J. Am. Soc. Hematol."},{"issue":"9","key":"10.1016\/j.leukres.2026.108326_bib157","first-page":"1071","article-title":"Adult T-cell leukemia: molecular basis for clonal expansion and transformation of HTLV-1\u2013infected T cells","volume":"129","author":"Watanabe","year":"2017","journal-title":"Blood J. Am. Soc. Hematol."},{"issue":"1","key":"10.1016\/j.leukres.2026.108326_bib158","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.virol.2003.10.002","article-title":"Garc\u0131a-Arenal F. Variability and genetic structure of the population of watermelon mosaic virus infecting melon in Spain","volume":"318","author":"Moreno","year":"2004","journal-title":"Virology"},{"issue":"3","key":"10.1016\/j.leukres.2026.108326_bib159","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1073\/pnas.0507631103","article-title":"HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells","volume":"103","author":"Satou","year":"2006","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.leukres.2026.108326_bib160","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.3389\/fmicb.2016.01443","article-title":"Transcription profiling analysis of mango\u2013Fusarium mangiferae interaction","volume":"7","author":"Liu","year":"2016","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.leukres.2026.108326_bib161","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2020.106316","article-title":"Osteopontin-c is overexpressed in KMT2A-AFF1 positive pediatric B-cell lymphoblastic leukemia when compared to those with ETV6-RUNX1","volume":"91","author":"da Fonseca Bastos","year":"2020","journal-title":"Leuk. Res."},{"issue":"1","key":"10.1016\/j.leukres.2026.108326_bib162","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1470-2045(15)00464-7","article-title":"Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study","volume":"17","author":"Dimopoulos","year":"2016","journal-title":"Lancet Oncol."},{"issue":"8","key":"10.1016\/j.leukres.2026.108326_bib163","first-page":"983","article-title":"A T-cell\u2013directed chimeric antigen receptor for the selective treatment of T-cell malignancies","volume":"126","author":"Mamonkin","year":"2015","journal-title":"Blood J. Am. Soc. Hematol."},{"issue":"10","key":"10.1016\/j.leukres.2026.108326_bib164","first-page":"3625","article-title":"Clinical significance of CCR4 expression in adult T-cell leukemia\/lymphoma: its close association with skin involvement and unfavorable outcome","volume":"9","author":"Ishida","year":"2003","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.leukres.2026.108326_bib165","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1038\/sj.leu.2402972","article-title":"vitro cytotoxicity of aplidin and crossresistance with other cytotoxic drugs in childhood leukemic and normal bone marrow and blood samples: a rational basis for clinical development","volume":"17","author":"Bresters","year":"2003","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.leukres.2026.108326_bib166","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.2217\/imt.14.94","article-title":"Mogamulizumab and the treatment of CCR4-positive T-cell lymphomas","volume":"6","author":"Remer","year":"2014","journal-title":"Immunotherapy"},{"issue":"1","key":"10.1016\/j.leukres.2026.108326_bib167","first-page":"25","article-title":"Anti-CCR9 chimeric antigen receptor T cells for T-cell acute lymphoblastic leukemia","volume":"140","author":"Maciocia","year":"2022","journal-title":"Blood J. Am. Soc. Hematol."},{"issue":"4","key":"10.1016\/j.leukres.2026.108326_bib168","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.cell.2016.01.011","article-title":"Precision tumor recognition by T cells with combinatorial antigen-sensing circuits","volume":"164","author":"Roybal","year":"2016","journal-title":"Cell"},{"issue":"18","key":"10.1016\/j.leukres.2026.108326_bib169","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1056\/NEJMoa1106152","article-title":"Inducible apoptosis as a safety switch for adoptive cell therapy","volume":"365","author":"Di Stasi","year":"2011","journal-title":"New. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.leukres.2026.108326_bib170","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1038\/leu.2016.81","article-title":"Leukemia cell infiltration causes defective erythropoiesis partially through MIP-1\u03b1\/CCL3","volume":"30","author":"Wang","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2026.108326_bib171","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.3389\/fmicb.2018.02291","article-title":"Therapeutic targets in chlamydial fatty acid and phospholipid synthesis","volume":"9","author":"Yao","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.leukres.2026.108326_bib172","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.3389\/fmicb.2017.02565","article-title":"Role of L-particles during herpes simplex virus infection","volume":"8","author":"Heilingloh","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.leukres.2026.108326_bib173","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.3389\/fmicb.2018.03136","article-title":"Dairy cattle, a potential reservoir of human campylobacteriosis: epidemiological and molecular characterization of Campylobacter jejuni from cattle farms","volume":"9","author":"An","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.leukres.2026.108326_bib174","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.580371","article-title":"CRISPR genome editing applied to the pathogenic retrovirus HTLV-1","volume":"10","author":"Panfil","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"1","key":"10.1016\/j.leukres.2026.108326_bib175","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1080\/10717544.2018.1474964","article-title":"Delivering CRISPR: a review of the challenges and approaches","volume":"25","author":"Lino","year":"2018","journal-title":"Drug. Deliv."},{"issue":"9","key":"10.1016\/j.leukres.2026.108326_bib176","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nbt.2623","article-title":"High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells","volume":"31","author":"Fu","year":"2013","journal-title":"Nat. Biotechnol."},{"issue":"2","key":"10.1016\/j.leukres.2026.108326_bib177","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41591-018-0326-x","article-title":"Identification of preexisting adaptive immunity to Cas9 proteins in humans","volume":"25","author":"Charlesworth","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.leukres.2026.108326_bib178","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2020.106356","article-title":"Hemorrhage in acute promyelocytic leukemia: can it be predicted and prevented?","volume":"94","author":"Naymagon","year":"2020","journal-title":"Leuk. Res."},{"issue":"4-5","key":"10.1016\/j.leukres.2026.108326_bib179","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.drup.2009.06.001","article-title":"Therapeutic targeting of microenvironmental interactions in leukemia: mechanisms and approaches","volume":"12","author":"Konopleva","year":"2009","journal-title":"Drug. Resist. Updates"},{"issue":"11","key":"10.1016\/j.leukres.2026.108326_bib180","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1111\/j.1349-7006.2009.01284.x","article-title":"Hepatocellular carcinoma development induced by conditional \u03b2-catenin activation in Lkb1+\/\u2212 mice","volume":"100","author":"Miyoshi","year":"2009","journal-title":"Cancer Sci."},{"key":"10.1016\/j.leukres.2026.108326_bib181","article-title":"T\u2013cell Acute Lymphoblastic Leukemia in a Patient with Pre\u2013existing Essential Thrombocythemia: A Case Report and Literature Review","volume":"16","author":"Medawar","year":"2021","journal-title":"Leuk. Res. Rep."},{"issue":"10","key":"10.1016\/j.leukres.2026.108326_bib182","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1080\/10245332.2018.1486064","article-title":"Roles of the bone marrow niche in hematopoiesis, leukemogenesis, and chemotherapy resistance in acute myeloid leukemia","volume":"23","author":"Wang","year":"2018","journal-title":"Hematology"},{"issue":"12","key":"10.1016\/j.leukres.2026.108326_bib183","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.3390\/v12121422","article-title":"Extracellular vesicles in HTLV-1 communication: the story of an invisible messenger","volume":"12","author":"Al Sharif","year":"2020","journal-title":"Viruses"},{"issue":"9","key":"10.1016\/j.leukres.2026.108326_bib184","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1111\/cas.13303","article-title":"Genetic alterations in adult T-cell leukemia\/lymphoma","volume":"108","author":"Kogure","year":"2017","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.leukres.2026.108326_bib185","doi-asserted-by":"crossref","DOI":"10.1016\/j.bneo.2024.100054","article-title":"A phase 1 study of interleukin-15 in combination with mogamulizumab in relapsed and refractory T-cell malignancies","volume":"2","author":"Gordon","year":"2025","journal-title":"Blood Neoplasia"},{"issue":"18","key":"10.1016\/j.leukres.2026.108326_bib186","doi-asserted-by":"crossref","first-page":"9389","DOI":"10.1128\/JVI.76.18.9389-9397.2002","article-title":"5\u2032-long terminal repeat-selective CpG methylation of latent human T-cell leukemia virus type 1 provirus in vitro and in vivo","volume":"76","author":"Koiwa","year":"2002","journal-title":"J. Virol."},{"issue":"11","key":"10.1016\/j.leukres.2026.108326_bib187","first-page":"3113","article-title":"The host genomic environment of the provirus determines the abundance of HTLV-1\u2013infected T-cell clones","volume":"117","author":"Gillet","year":"2011","journal-title":"Blood J. Am. Soc. Hematol."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212626001700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212626001700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:16:55Z","timestamp":1790817415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212626001700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":187,"alternative-id":["S0145212626001700"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2026.108326","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HTLV-1 and ATL: Decoding Molecular Pathogenesis for Next\u2010Generation Therapies","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2026.108326","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108326"}}